IL-10 Regulates Mast Cell Function and Survival
IL-10 Regulates Mast Cell Function and Survival
批准号:
7343164
负责人:
John J Ryan
金额:
$36.22万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-01 至 2012-01-31
关键词:
AnaphylaxisApoptosisAreaArthritisAsthmaAutoimmune DiseasesCell Cycle ArrestCell ProliferationCell SurvivalCell physiologyChronicClinicalDataDiseaseDown-RegulationHeart DiseasesHomeostasisHumanHyperplasiaHypersensitivityIL2RA geneIgEIn VitroInfectionInflammationInflammatoryInjection of therapeutic agentInterleukin-10MediatingMediator of activation proteinModelingMultiple SclerosisMusNippostrongylusPathway interactionsProcessProductionRecruitment ActivityResearch PersonnelRoleSignal TransductionSourceSurfaceSystemT-LymphocyteTestingautocrineautoimmune arthritisin vivoin vivo Modelmast cellmastocytosisparacrinepreventreceptor expressionresponsetool
中文摘要
描述(由申请人提供):我们的建议将调查临床上重要的领域肥大细胞稳态。肥大细胞因其在过敏和哮喘中的作用而闻名,并且最近被认为与炎症性疾病如多发性硬化症、关节炎和心脏病有关。对炎症性疾病的理解中的一个关键差距是肥大细胞反应通常如何被抑制以防止慢性炎症。我们的假设是IL-10是肥大细胞稳态的内源性介质。我们提出了明确的证据表明,IL-10抑制小鼠和人类肥大细胞的功能和生存。初步的体内研究证实了这些数据。我们还表明,IL-10可能由两种来源提供:(I)活化肥大细胞的自分泌产物,和(II)CD 25+调节性T细胞(Treg)的旁分泌产物。操纵肥大细胞内稳态可能是治疗炎症性疾病的有力工具。我们的具体目标是:一。确定IL-10如何在体外和体内抑制IgE受体表达和功能。我们将测试以下假设:A。IL-10利用Stat 5抑制Fc?RI通过抑制Syk、Akt和Stat 5的表达发挥作用。B。IL-10抑制Fc?RI表达,并减轻IgE介导的过敏反应。C. IL-10由活化的肥大细胞和募集的T细胞提供。D.甲状腺激素通过产生IL-10抑制肥大细胞的体内功能。二.确定IL-10如何在体外和体内抑制肥大细胞增殖和存活。我们将测试以下假设:A。IL-10通过抑制Stat 5和Akt的表达诱导肥大细胞的细胞周期阻滞和凋亡。B。胸腺肽通过分泌IL-10抑制肥大细胞增殖和存活。C. IL-10,可能来源于TGF 1 α,在体内抑制肥大细胞增生。
英文摘要
DESCRIPTION (provided by applicant): Our proposal will investigate the clinically important area of mast cell homeostasis. Mast cells are well-known for their role in allergy and asthma, and have recently been implicated in inflammatory disorders such as multiple sclerosis, arthritis, and heart disease. A critical gap in the understanding of inflammatory disease is how the mast cell response is normally dampened to prevent chronic inflammation. Our hypothesis is that IL-10 is an endogenous mediator of mast cell homeostasis. We present clear evidence that IL-10 suppresses the function and survival of mouse and human mast cells. Preliminary in vivo studies corroborate these data. We also show that IL-10 may be provided by two sources: (I) autocrine production from activated mast cells, and (II) paracrine production from CD25+ regulatory T cells (Treg). Manipulating mast cell homeostasis could be a powerful tool for the treatment of inflammatory disease. Our Specific Aims are: I. To determine how IL-10 suppresses IgE receptor expression and function in vitro and in vivo. We will test the following hypotheses: A. IL-10 employs Stat5 to inhibit Fc?RI function, by suppressing Syk, Akt, and Stat5 expression. B. IL-10 suppresses Fc?RI expression in vivo, and mitigates IgE-mediated anaphylaxis. C. IL-10 is provided by activated mast cells and by recruited Tregs. D. Tregs suppress mast cell function in vivo by producing IL-10. II. To determine how IL-10 inhibits mast cell proliferation and survival in vitro and in vivo. We will test the following hypotheses: A. IL-10 induces cell cycle arrest and apoptosis in mast cells by inhibiting Stat5 and Akt expression. B. Tregs inhibit mast cell proliferation and survival by secreting IL-10. C. IL-10, possibly derived from Tregs, suppresses mast cell hyperplasia in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
-
批准号:10317599
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2021
-
负责人:John J Ryan
-
依托单位:
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
-
批准号:10456994
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2021
-
负责人:John J Ryan
-
依托单位:
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
-
批准号:10669711
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2021
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:10459343
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:10219074
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:9757681
-
项目类别:
-
资助金额:$49.67万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:10542649
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:10458921
-
项目类别:
-
资助金额:$6.83万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:9794165
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
-
批准号:10116077
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2018
-
负责人:John J Ryan
-
依托单位:
Control of IgG-mediated Inflammation by Fyn and Lyn Kinases
-
批准号:8634017
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2013
-
负责人:John J Ryan
-
依托单位:
Control of IgG-mediated Inflammation by Fyn and Lyn Kinases
-
批准号:8500877
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2013
-
负责人:John J Ryan
-
依托单位:
Mast Cell Function in Protective And Pathological Immunity: A Role for MDSC?
-
批准号:8514221
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2012
-
负责人:John J Ryan
-
依托单位:
VCU Minority Access to Research Careers Program (VCU-MARC)
-
批准号:8073651
-
项目类别:
-
资助金额:$27.79万
-
财政年份:2010
-
负责人:John J Ryan
-
依托单位:
VCU Minority Access to Research Careers Program (VCU-MARC)
-
批准号:8469522
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2010
-
负责人:John J Ryan
-
依托单位:
VCU Minority Access to Research Careers Program (VCU-MARC)
-
批准号:8268970
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2010
-
负责人:John J Ryan
-
依托单位:
VCU Minority Access to Research Careers Program (VCU-MARC)
-
批准号:7858920
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2010
-
负责人:John J Ryan
-
依托单位:
VCU Minority Access to Research Careers Program (VCU-MARC)
-
批准号:8664880
-
项目类别:
-
资助金额:$11.0万
-
财政年份:2010
-
负责人:John J Ryan
-
依托单位:
The Effect of Lyn Deficiency on Mast Cell Activation and Inflammatory Disease Pro
-
批准号:7476202
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2008
-
负责人:John J Ryan
-
依托单位:
IL-10 Controls Mast Cell Homeostasis
-
批准号:8577549
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2007
-
负责人:John J Ryan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: